US Stock MarketDetailed Quotes

Bicycle Therapeutics (BCYC)

Watchlist
  • 3.930
  • -0.020-0.51%
Trading Jul 28 10:04 ET
274.36MMarket Cap-1.25P/E (TTM)

Bicycle Therapeutics (BCYC) Income Statement

Quarterly·All
YOY yoy
Hide blank lines yoy
Currency: USD
2026/Q1
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
2023/Q2
2023/Q1
2022/Q4
2022/Q3
2022/Q2
2022/Q1
2021/Q4
2021/Q3
2021/Q2
Total Revenue as Reported
-91.11%887.00K
+1193.28%47.96M
+338.49%11.73M
-68.81%2.92M
-48.91%9.98M
-30.44%3.71M
-50.00%2.68M
-17.86%9.36M
+298.90%19.53M
+67.38%5.33M
+76.05%5.35M
+160.32%11.40M
+26.84%4.90M
-15.54%3.19M
-29.84%3.04M
+145.27%4.38M
+113.50%3.86M
-2.00%3.77M
+12.78%4.33M
+13.62%1.79M
Total Operating Revenue
-91.11%887.00K
+1193.28%47.96M
+338.49%11.73M
-68.81%2.92M
-48.91%9.98M
-30.44%3.71M
-50.00%2.68M
-17.86%9.36M
+298.90%19.53M
+67.38%5.33M
+76.05%5.35M
+160.32%11.40M
+26.84%4.90M
-15.54%3.19M
-29.84%3.04M
+145.27%4.38M
+113.50%3.86M
-2.00%3.77M
+12.78%4.33M
+13.62%1.79M
Operating Expense
-16.89%66.48M
+2.56%72.61M
+16.98%77.44M
+60.88%90.27M
+55.86%79.98M
+17.33%70.80M
+19.42%66.20M
+2.21%56.11M
+10.97%51.32M
+67.67%60.34M
+67.99%55.44M
+77.10%54.90M
+48.56%46.25M
+66.02%35.99M
+75.70%33.00M
+62.57%31.00M
+75.00%31.13M
+7.24%21.68M
+36.40%18.78M
+33.79%19.07M
Selling and Admin Expenses
-16.01%17.58M
-0.85%20.84M
+6.02%19.02M
+19.86%19.24M
+27.17%20.92M
+34.35%21.02M
+15.23%17.94M
+5.75%16.05M
+17.23%16.45M
+38.83%15.65M
+51.92%15.57M
+36.20%15.18M
-16.69%14.04M
+29.21%11.27M
+23.94%10.25M
+51.70%11.14M
+108.08%16.85M
-14.13%8.72M
+29.07%8.27M
+16.71%7.35M
-General & Admin Expense
-16.01%17.58M
-0.85%20.84M
+6.02%19.02M
+19.86%19.24M
+27.17%20.92M
+34.35%21.02M
+15.23%17.94M
+5.75%16.05M
+17.23%16.45M
+38.83%15.65M
+51.92%15.57M
+36.20%15.18M
-16.69%14.04M
+29.21%11.27M
+23.94%10.25M
+51.70%11.14M
+108.08%16.85M
-14.13%8.72M
+29.07%8.27M
+16.71%7.35M
Research & Development
-17.20%48.90M
+4.00%51.77M
+21.05%58.43M
+77.31%71.03M
+69.40%59.06M
+11.37%49.78M
+21.06%48.27M
+0.85%40.06M
+8.24%34.86M
+80.82%44.70M
+75.23%39.87M
+100.06%39.72M
+125.50%32.21M
+90.79%24.72M
+116.42%22.75M
+69.37%19.85M
+47.36%14.28M
+28.81%12.96M
+42.78%10.51M
+47.30%11.72M
Operating Profit
+6.31%-65.59M
+63.25%-24.66M
-3.43%-65.71M
-86.85%-87.35M
-120.23%-70.01M
-21.96%-67.09M
-26.84%-63.53M
-7.46%-46.75M
+23.13%-31.79M
-67.70%-55.01M
-67.17%-50.08M
-63.41%-43.50M
-51.63%-41.35M
-83.19%-32.80M
-107.36%-29.96M
-54.02%-26.62M
-70.64%-27.27M
-9.41%-17.91M
-45.54%-14.45M
-36.29%-17.28M
Net Non-Operating Interest Income (Expense)
-42.26%4.83M
-43.23%5.82M
-36.91%6.66M
+6.75%7.42M
+74.12%8.36M
+87.88%10.25M
+232.70%10.55M
+77322.22%6.95M
+126.45%4.80M
+200.94%5.46M
+170.10%3.17M
-136.00%-9.00K
+453.50%2.12M
+338.24%1.81M
+246.93%1.17M
+103.14%25.00K
-18.34%-600.00K
-77.39%-761.00K
-1209.72%-799.00K
-314.56%-796.00K
Non-Operating Interest Income
-42.04%4.88M
-42.97%5.88M
-36.69%6.70M
-3.87%7.47M
+49.61%8.41M
+64.17%10.30M
+165.57%10.58M
+857.39%7.77M
+92.01%5.62M
+137.82%6.28M
+100.15%3.99M
-10.57%812.00K
+1243.58%2.93M
+4372.88%2.64M
+8195.83%1.99M
+3847.83%908.00K
+1353.33%218.00K
+110.71%59.00K
-66.67%24.00K
-93.80%23.00K
Non-Operating Interest Expense
-5.88%48.00K
+9.62%57.00K
+33.33%44.00K
-93.45%54.00K
-93.79%51.00K
-93.66%52.00K
-95.95%33.00K
+0.37%824.00K
+1.61%821.00K
-0.73%820.00K
-0.37%814.00K
-7.02%821.00K
-1.22%808.00K
+0.73%826.00K
-0.73%817.00K
+7.81%883.00K
+56.70%818.00K
+79.43%820.00K
--823.00K
--819.00K
Other Income (Expense)
+153.77%107.00K
-101.31%-51.00K
+112.41%158.00K
+637.62%745.00K
-380.28%-199.00K
+2033.33%3.90M
-78.29%-1.27M
-74.10%101.00K
+115.67%71.00K
--183.00K
-457.00%-714.00K
+157.35%390.00K
-300.88%-453.00K
----
+29.87%200.00K
-11433.33%-680.00K
-162.79%-113.00K
----
+120.59%154.00K
-93.88%6.00K
Gain on Sale of Security
+153.77%107.00K
+91.08%-51.00K
+149.53%158.00K
+637.62%745.00K
-380.28%-199.00K
-412.57%-572.00K
+55.32%-319.00K
-74.10%101.00K
+115.67%71.00K
--183.00K
-457.00%-714.00K
+157.35%390.00K
-300.88%-453.00K
----
+29.87%200.00K
-11433.33%-680.00K
-162.79%-113.00K
----
+120.59%154.00K
-93.88%6.00K
Special Income (Charges)
----
-100.00%0.00
+100.00%0.00
----
----
--4.48M
---954.00K
----
----
--0.00
--0.00
----
----
----
----
----
----
----
----
----
-Less:Other Special Charges
----
----
----
----
----
---4.48M
--954.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
Pretax Profit
+1.92%-60.65M
+64.32%-18.89M
-8.56%-58.90M
-99.47%-79.18M
-129.78%-61.84M
-8.52%-52.94M
-13.91%-54.25M
+7.94%-39.70M
+32.18%-26.91M
-60.47%-48.78M
-66.61%-47.63M
-58.09%-43.12M
-41.81%-39.68M
-61.82%-30.40M
-89.39%-28.59M
-50.92%-27.28M
-69.28%-27.98M
-7.41%-18.79M
-42.35%-15.09M
-47.99%-18.07M
Tax
+115.82%172.00K
+216.91%1.27M
+105.95%205.00K
-300.87%-231.00K
-210.57%-1.09M
-438.13%-1.08M
-251.76%-3.45M
+122.24%115.00K
+43.37%-350.00K
+176.19%320.00K
+1054.62%2.27M
-15.66%-517.00K
-47.49%-618.00K
+43.85%-420.00K
+42.65%-238.00K
-179.38%-447.00K
-23.24%-419.00K
-1235.71%-748.00K
+10.75%-415.00K
-64.95%-160.00K
Net Profit
-0.12%-60.83M
+61.13%-20.15M
-16.33%-59.10M
-98.31%-78.95M
-128.72%-60.75M
-5.61%-51.85M
-1.81%-50.80M
+6.55%-39.81M
+32.00%-26.56M
-63.78%-49.10M
-76.03%-49.90M
-58.80%-42.60M
-41.72%-39.06M
-66.20%-29.98M
-93.13%-28.35M
-49.77%-26.83M
-70.24%-27.56M
-3.46%-18.04M
-44.78%-14.68M
-47.86%-17.91M
Profit from Continuing Operations
-0.12%-60.83M
+61.13%-20.15M
-16.33%-59.10M
-98.31%-78.95M
-128.72%-60.75M
-5.61%-51.85M
-1.81%-50.80M
+6.55%-39.81M
+32.00%-26.56M
-63.78%-49.10M
-76.03%-49.90M
-58.80%-42.60M
-41.72%-39.06M
-66.20%-29.98M
-93.13%-28.35M
-49.77%-26.83M
-70.24%-27.56M
-3.46%-18.04M
-44.78%-14.68M
-47.86%-17.91M
Net Income to Parent Company
-0.12%-60.83M
+61.13%-20.15M
-16.33%-59.10M
-98.31%-78.95M
-128.72%-60.75M
-5.61%-51.85M
-1.81%-50.80M
+6.55%-39.81M
+32.00%-26.56M
-63.78%-49.10M
-76.03%-49.90M
-58.80%-42.60M
-41.72%-39.06M
-66.20%-29.98M
-93.13%-28.35M
-49.77%-26.83M
-70.24%-27.56M
-3.46%-18.04M
-44.78%-14.68M
-47.86%-17.91M
Net Income to Common Stockholders
-0.12%-60.83M
+61.13%-20.15M
-16.33%-59.10M
-98.31%-78.95M
-128.72%-60.75M
-5.61%-51.85M
-1.81%-50.80M
+6.55%-39.81M
+32.00%-26.56M
-63.78%-49.10M
-76.03%-49.90M
-58.80%-42.60M
-41.72%-39.06M
-66.20%-29.98M
-93.13%-28.35M
-49.77%-26.83M
-70.24%-27.56M
-3.46%-18.04M
-44.78%-14.68M
-47.86%-17.91M
Basic EPS
+1.14%-0.87
+61.33%-0.29
-14.86%-0.85
-48.05%-1.14
-41.94%-0.88
+35.34%-0.75
+41.27%-0.74
+45.39%-0.77
+52.31%-0.62
-14.85%-1.16
-31.25%-1.26
-56.67%-1.41
-39.78%-1.30
-60.32%-1.01
-62.71%-0.96
-21.62%-0.90
-27.40%-0.93
+24.10%-0.63
-13.46%-0.59
-10.45%-0.74
Diluted EPS
+1.14%-0.87
+61.33%-0.29
-14.86%-0.85
-48.05%-1.14
-41.94%-0.88
+35.34%-0.75
+41.27%-0.74
+45.39%-0.77
+52.31%-0.62
-14.85%-1.16
-31.25%-1.26
-56.67%-1.41
-39.78%-1.30
-60.32%-1.01
-62.71%-0.96
-21.62%-0.90
-27.40%-0.93
+24.10%-0.63
-13.46%-0.59
-10.45%-0.74
Deadline
Mar 31, 2026
Dec 31, 2025
Sep 30, 2025
Jun 30, 2025
Mar 31, 2025
Dec 31, 2024
Sep 30, 2024
Jun 30, 2024
Mar 31, 2024
Dec 31, 2023
Sep 30, 2023
Jun 30, 2023
Mar 31, 2023
Dec 31, 2022
Sep 30, 2022
Jun 30, 2022
Mar 31, 2022
Dec 31, 2021
Sep 30, 2021
Jun 30, 2021
Accounting Standard
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
2026/Q12025/Q42025/Q32025/Q22025/Q12024/Q42024/Q32024/Q22024/Q12023/Q42023/Q32023/Q22023/Q12022/Q42022/Q32022/Q22022/Q12021/Q42021/Q32021/Q2
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of de-escalation in U.S.-Iran military tensions have emerged, pushing international oil prices lower. Trump ordered the U.S. military Show More